Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, van der Heijde DM, Shea B, Christensen R, Coates L, Eder L, McHugh N, Kalyoncu U, Steinkoenig I, Ogdie A.

J Rheumatol. 2017 Oct;44(10):1522-1528. doi: 10.3899/jrheum.160904. Epub 2017 Feb 1.

2.

Why CAPS criteria are not diagnostic criteria?

Landewé RB, van der Heijde DM.

Ann Rheum Dis. 2017 Apr;76(4):e7. doi: 10.1136/annrheumdis-2016-210656. Epub 2016 Oct 31. No abstract available.

PMID:
27799158
3.

Automated joint space width quantification of hand and wrist joints: a proof of concept study.

Huo Y, Veldhuizen RD, van der Heijde DM, Besselink NJ, Jacobs JW, van Laar JM, Viergever MA, Vincken KL, Lafeber FP, de Hair MJ; Society for Rheumatology Research Utrecht investigators.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S34-S39. Epub 2016 Oct 18.

4.

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016.

Winthrop KL, Strand V, van der Heijde DM, Mease PJ, Crow MK, Weinblatt M, Bathon JM, Buch MH, Burmester GR, Dougados M, Kay J, Mariette X, Breedveld FC, Kalden JR, Smolen JS, Furst DE.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):69-76. Epub 2016 Aug 3.

5.

Instruments Measuring Pain, Physical Function, or Patient's Global Assessment in Hand Osteoarthritis: A Systematic Literature Search.

Visser AW, Bøyesen P, Haugen IK, Schoones JW, van der Heijde DM, Rosendaal FR, Kloppenburg M.

J Rheumatol. 2015 Nov;42(11):2118-34. doi: 10.3899/jrheum.141228. Epub 2015 Oct 15. Review.

PMID:
26472412
6.

The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.

Danila MI, Westfall AO, Raman K, Chen L, Reynolds RJ, Hughes LB, Arnett DK, McGwin G, Szalai AJ, van der Heijde DM, Conn D, Callahan LF, Moreland LW, Bridges SL Jr.

Genes Immun. 2015 Oct;16(7):446-51. doi: 10.1038/gene.2015.24. Epub 2015 Jul 30.

7.

Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.

Kloppenburg M, Bøyesen P, Visser AW, Haugen IK, Boers M, Boonen A, Conaghan PG, Hawker GA, Kvien TK, Landewé R, Uhlig T, Smeets W, Greibrokk E, van der Heijde DM.

J Rheumatol. 2015 Nov;42(11):2190-7. doi: 10.3899/jrheum.141017. Epub 2015 Jul 1. Review.

PMID:
26136489
8.

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH.

J Rheumatol. 2015 Aug;42(8):1383-91. doi: 10.3899/jrheum.140741. Epub 2015 Jun 15.

PMID:
26077402
9.

Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study.

van der Have M, Brakenhoff LK, van Erp SJ, Kaptein AA, Leenders M, Scharloo M, Veenendaal RA, van der Heijde DM, van der Meulen-de Jong AE, Hommes DW, Fidder HH.

J Crohns Colitis. 2015 Mar;9(3):276-83. doi: 10.1093/ecco-jcc/jju025. Epub 2014 Dec 28.

PMID:
25547976
10.

Radiographic scoring methods in hand osteoarthritis--a systematic literature search and descriptive review.

Visser AW, Bøyesen P, Haugen IK, Schoones JW, van der Heijde DM, Rosendaal FR, Kloppenburg M.

Osteoarthritis Cartilage. 2014 Oct;22(10):1710-23. doi: 10.1016/j.joca.2014.05.026. Review.

11.

A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist.

Genovese MC, van der Heijde DM, Keystone EC, Spindler AJ, Benhamou C, Kavanaugh A, Fudman E, Lampl K, O'Brien C, Duffield EL, Poiley J, Weinblatt ME.

J Rheumatol. 2014 Nov;41(11):2120-8. doi: 10.3899/jrheum.140238. Epub 2014 Sep 15.

PMID:
25225285
12.

Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review.

Vinik O, Wechalekar MD, Falzon L, Buchbinder R, van der Heijde DM, Bombardier C.

J Rheumatol Suppl. 2014 Sep;92:70-4. doi: 10.3899/jrheum.140465. Review.

PMID:
25180131
13.

Interventions for tophi in gout: a Cochrane systematic literature review.

Sriranganathan MK, Vinik O, Falzon L, Bombardier C, van der Heijde DM, Edwards CJ.

J Rheumatol Suppl. 2014 Sep;92:63-9. doi: 10.3899/jrheum.140464. Review.

PMID:
25180130
14.

Treatment target and followup measures for patients with gout: a systematic literature review.

Andrés M, Sivera F, Falzon L, van der Heijde DM, Carmona L.

J Rheumatol Suppl. 2014 Sep;92:55-62. doi: 10.3899/jrheum.140463. Review.

PMID:
25180129
15.

Treatment of gout patients with impairment of renal function: a systematic literature review.

van Echteld IA, van Durme C, Falzon L, Landewé RB, van der Heijde DM, Aletaha D.

J Rheumatol Suppl. 2014 Sep;92:48-54. doi: 10.3899/jrheum.140462. Review.

PMID:
25180128
16.

Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review.

Seth R, Kydd AS, Falzon L, Bombardier C, van der Heijde DM, Edwards CJ.

J Rheumatol Suppl. 2014 Sep;92:42-7. doi: 10.3899/jrheum.140461. Review.

PMID:
25180127
17.

Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.

Kydd AS, Seth R, Buchbinder R, Falzon L, Edwards CJ, van der Heijde DM, Bombardier C.

J Rheumatol Suppl. 2014 Sep;92:33-41. doi: 10.3899/jrheum.140460. Review.

PMID:
25180126
18.

Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviews.

Moi JH, Sriranganathan MK, Falzon L, Edwards CJ, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2014 Sep;92:26-32. doi: 10.3899/jrheum.140459. Review.

PMID:
25180125
19.

The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.

Wechalekar MD, Vinik O, Moi JH, Sivera F, van Echteld IA, van Durme C, Falzon L, Bombardier C, Carmona L, Aletaha D, Landewé RB, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2014 Sep;92:15-25. doi: 10.3899/jrheum.140458. Review.

PMID:
25180124
20.

Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature.

van Durme C, van Echteld IA, Falzon L, Aletaha D, van der Heijde DM, Landewé RB.

J Rheumatol Suppl. 2014 Sep;92:9-14. doi: 10.3899/jrheum.140457. Review.

PMID:
25180123
21.

Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review.

Sivera F, Andrès M, Falzon L, van der Heijde DM, Carmona L.

J Rheumatol Suppl. 2014 Sep;92:3-8. doi: 10.3899/jrheum.140456. Review.

PMID:
25180122
22.

When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).

Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS.

J Rheumatol. 2014 Oct;41(10):1922-34. doi: 10.3899/jrheum.131238. Epub 2014 Aug 15.

PMID:
25128520
23.

Is HLA-B27 increased in patients diagnosed with undifferentiated arthritis? Results from the Leiden early arthritis cohort.

van Gaalen F, van den Berg R, Verhoog I, Schonkeren J, van der Helm-van Mil A, Huizinga T, van der Heijde DM.

J Rheumatol. 2014 Oct;41(10):1948-51. doi: 10.3899/jrheum.131462. Epub 2014 Aug 15.

PMID:
25128507
24.

Frequency of joint involvement in juvenile idiopathic arthritis during a 5-year follow-up of newly diagnosed patients: implications for MR imaging as outcome measure.

Hemke R, Nusman CM, van der Heijde DM, Doria AS, Kuijpers TW, Maas M, van Rossum MA.

Rheumatol Int. 2015 Feb;35(2):351-7. doi: 10.1007/s00296-014-3108-x. Epub 2014 Aug 14.

PMID:
25119829
25.

Bone marrow edema on magnetic resonance imaging (MRI) of the sacroiliac joints is associated with development of fatty lesions on MRI over a 1-year interval in patients with early inflammatory low back pain: a 2-year followup study.

van Onna M, van Tubergen A, van der Heijde DM, Jurik AG, Landewé R.

J Rheumatol. 2014 Jun;41(6):1088-94. doi: 10.3899/jrheum.131022. Epub 2014 Apr 15.

PMID:
24737909
26.

Magnetic resonance imaging of the hand joints in patients with inflammatory bowel disease and arthralgia: a pilot study.

Brakenhoff LK, Stomp W, van Gaalen FA, Hommes DW, Bloem JL, van der Heijde DM, Fidder HH, Reijnierse M.

Scand J Rheumatol. 2014;43(5):416-8. doi: 10.3109/03009742.2014.882407. Epub 2014 Apr 11.

PMID:
24720480
27.

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.

Tugwell P, Boers M, D'Agostino MA, Beaton D, Boonen A, Bingham CO 3rd, Choy E, Conaghan PG, Dougados M, Duarte C, Furst DE, Guillemin F, Gossec L, Heiberg T, van der Heijde DM, Hewlett S, Kirwan JR, Kvien TK, Landewé RB, Mease PJ, Østergaard M, Simon L, Singh JA, Strand V, Wells G.

J Rheumatol. 2014 May;41(5):1000-4. doi: 10.3899/jrheum.131310. Epub 2014 Apr 1.

28.

Updating the OMERACT filter: discrimination and feasibility.

Wells G, Beaton DE, Tugwell P, Boers M, Kirwan JR, Bingham CO 3rd, Boonen A, Brooks P, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Gossec L, Guillemin F, Helliwell P, Hewlett S, Kvien TK, Landewé RB, March L, Mease PJ, Ostergaard M, Simon L, Singh JA, Strand V, van der Heijde DM.

J Rheumatol. 2014 May;41(5):1005-10. doi: 10.3899/jrheum.131311. Epub 2014 Apr 1.

29.

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewé RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2014 May;41(5):994-9. doi: 10.3899/jrheum.131309. Epub 2014 Mar 15.

30.

A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial.

Nam JL, Villeneuve E, Hensor EM, Wakefield RJ, Conaghan PG, Green MJ, Gough A, Quinn M, Reece R, Cox SR, Buch MH, van der Heijde DM, Emery P.

Ann Rheum Dis. 2014 Jun;73(6):1027-36. doi: 10.1136/annrheumdis-2013-204882. Epub 2014 Mar 11.

PMID:
24618266
31.

Report from the OMERACT Hand Osteoarthritis Special Interest Group: advances and future research priorities.

Kloppenburg M, Bøyesen P, Smeets W, Haugen IK, Liu R, Visser W, van der Heijde DM.

J Rheumatol. 2014 Apr;41(4):810-8. doi: 10.3899/jrheum.131253. Epub 2014 Jan 15. Review. Erratum in: J Rheumatol. 2014 May;41(5):1033. Haugen, Ida [corrected to Haugen, Ida K].

PMID:
24429165
32.

Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, van der Heijde DM, Gregersen PK, Lindqvist E, Huizinga TW, Gröndal G, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Jul;73(7):1384-7. doi: 10.1136/annrheumdis-2013-203940. Epub 2014 Jan 3.

PMID:
24389296
33.

Selecting magnetic resonance imaging (MRI) outcome measures for juvenile idiopathic arthritis (JIA) clinical trials: first report of the MRI in JIA special interest group.

Hemke R, Doria AS, Tzaribachev N, Maas M, van der Heijde DM, van Rossum MA.

J Rheumatol. 2014 Feb;41(2):354-8. doi: 10.3899/jrheum.131081. Epub 2013 Nov 1.

PMID:
24187109
34.

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P.

Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2.

PMID:
23912798
35.

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewé RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Müller-Ladner U, Ostergaard M, Zochling J, Falzon L, van der Heijde DM.

Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.

36.

Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis.

Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, Houwing-Duistermaat JJ, van der Helm-van Mil AH.

Scand J Rheumatol. 2013;42(3):182-9. doi: 10.3109/03009742.2012.728618. Epub 2013 Feb 20.

PMID:
23425151
37.

Improvement in deployment of MRI of the sacroiliac joints in patients suspected for spondyloarthritis using a targeted intervention: a case study.

Vossen MH, den Broeder AA, Hendriks-Roelofs F, van der Heijde DM, Reijnierse M.

Rheumatology (Oxford). 2013 May;52(5):933-8. doi: 10.1093/rheumatology/kes405. Epub 2013 Jan 18.

PMID:
23335636
38.

MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis.

Krabben A, Stomp W, van der Heijde DM, van Nies JA, Bloem JL, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2013 Sep 1;72(9):1540-4. doi: 10.1136/annrheumdis-2012-202628. Epub 2013 Jan 19.

PMID:
23334211
39.

Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic review.

Marks JL, van der Heijde DM, Colebatch AN, Buchbinder R, Edwards CJ.

J Rheumatol Suppl. 2012 Sep;90:81-4. doi: 10.3899/jrheum.120347. Review.

PMID:
22942334
40.

How do gastrointestinal or liver comorbidities influence the choice of pain treatment in inflammatory arthritis? A Cochrane systematic review.

Radner H, Ramiro S, van der Heijde DM, Landewé R, Buchbinder R, Aletaha D.

J Rheumatol Suppl. 2012 Sep;90:74-80. doi: 10.3899/jrheum.120346. Review.

PMID:
22942333
41.

Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review.

Colebatch AN, Marks JL, van der Heijde DM, Edwards CJ.

J Rheumatol Suppl. 2012 Sep;90:62-73. doi: 10.3899/jrheum.120345. Review.

PMID:
22942332
42.

Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review.

Adams K, Bombardier C, van der Heijde DM.

J Rheumatol Suppl. 2012 Sep;90:59-61. doi: 10.3899/jrheum.120344. Review.

PMID:
22942331
43.

Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review.

Ramiro S, Radner H, van der Heijde DM, Buchbinder R, Aletaha D, Landewé RB.

J Rheumatol Suppl. 2012 Sep;90:47-55. doi: 10.3899/jrheum.120342. Review.

PMID:
22942329
44.

The efficacy and safety of opioids in inflammatory arthritis: a Cochrane systematic review.

Whittle SL, Richards BL, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2012 Sep;90:40-6. doi: 10.3899/jrheum.120341. Review.

PMID:
22942328
45.

The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review.

Richards BL, Whittle SL, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2012 Sep;90:34-9. doi: 10.3899/jrheum.120340. Review.

PMID:
22942327
46.

Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review.

Richards BL, Whittle SL, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2012 Sep;90:28-33. doi: 10.3899/jrheum.120339. Review.

PMID:
22942326
47.

The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.

Richards BL, Whittle SL, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2012 Sep;90:21-7. doi: 10.3899/jrheum.120338. Review.

PMID:
22942325
48.

The role of corticosteroids for pain relief in persistent pain of inflammatory arthritis: a systematic literature review.

Tarner IH, Englbrecht M, Schneider M, van der Heijde DM, Müller-Ladner U.

J Rheumatol Suppl. 2012 Sep;90:17-20. doi: 10.3899/jrheum.120337. Review.

PMID:
22942324
49.

Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review.

Hazlewood G, van der Heijde DM, Bombardier C.

J Rheumatol Suppl. 2012 Sep;90:11-6. doi: 10.3899/jrheum.120336. Review.

PMID:
22942323
50.

Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review.

Englbrecht M, Tarner IH, van der Heijde DM, Manger B, Bombardier C, Müller-Ladner U.

J Rheumatol Suppl. 2012 Sep;90:3-10. doi: 10.3899/jrheum.120335. Review.

PMID:
22942322

Supplemental Content

Loading ...
Support Center